LeMaitre Vascular (NASDAQ:LMAT) Updates FY24 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $1.91 to $1.96 for the period, compared to the consensus estimate of $1.85. The company issued revenue guidance of $219.0 million to $221.0 million, compared to the consensus revenue estimate of $218.32 million. LeMaitre Vascular also updated its FY 2024 guidance to 1.910-1.960 EPS.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Cantor Fitzgerald assumed coverage on LeMaitre Vascular in a research report on Tuesday, October 15th. They issued a “neutral” rating and a $96.00 target price for the company. Barrington Research increased their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a report on Friday. Lake Street Capital initiated coverage on shares of LeMaitre Vascular in a report on Friday, August 2nd. They set a “buy” rating and a $105.00 price objective on the stock. StockNews.com cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Tuesday, August 27th. Finally, JMP Securities upped their target price on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the stock a “market outperform” rating in a report on Tuesday, August 20th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $94.57.

LeMaitre Vascular Price Performance

Shares of NASDAQ LMAT traded up $6.49 during mid-day trading on Friday, reaching $94.88. 343,645 shares of the company’s stock were exchanged, compared to its average volume of 105,134. The firm has a 50-day moving average price of $89.59 and a two-hundred day moving average price of $83.25. The firm has a market capitalization of $2.13 billion, a price-to-earnings ratio of 51.85, a price-to-earnings-growth ratio of 2.32 and a beta of 0.89. LeMaitre Vascular has a 52 week low of $45.96 and a 52 week high of $101.67.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings data on Thursday, October 31st. The medical instruments supplier reported $0.49 EPS for the quarter, topping the consensus estimate of $0.44 by $0.05. The business had revenue of $54.82 million for the quarter, compared to analyst estimates of $53.50 million. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.39%. The company’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.33 earnings per share. As a group, sell-side analysts forecast that LeMaitre Vascular will post 1.86 EPS for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 5th. Investors of record on Thursday, November 21st will be paid a $0.16 dividend. The ex-dividend date of this dividend is Thursday, November 21st. This represents a $0.64 annualized dividend and a yield of 0.67%. LeMaitre Vascular’s payout ratio is 34.97%.

Insiders Place Their Bets

In other LeMaitre Vascular news, Director David B. Roberts sold 3,063 shares of the stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $82.07, for a total value of $251,380.41. Following the sale, the director now directly owns 14,114 shares in the company, valued at $1,158,335.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 10.79% of the company’s stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.